← Open Payments lookup

RACHEL SANDERSON: Open Payments

NPI 1497201677 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,508 in 100 payments from 12 companies in 2025. Trend: 2023 $1,120 · 2024 $1,119 · 2025 $1,508

Food & beverage: $1,449Education: $59
CompanyPaymentsAmount
Novo Nordisk Inc24$304
ABBVIE INC.18$280
PFIZER INC.17$236
Vanda Pharmaceuticals Inc.10$156
Lilly USA, LLC10$148
Otsuka America Pharmaceutical, Inc.4$83
Boehringer Ingelheim Pharmaceuticals, Inc.4$68
Phathom Pharmaceuticals, Inc.4$68
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$52
Astellas Pharma US Inc2$50

Products named: VRAYLAR, Ozempic, NURTEC ODT, FANAPT, MOUNJARO, REXULTI, JARDIANCE, VOQUEZNA.

Industry payments across IN — which companies pay providers there.